Invites Biocore Co Ltd (216400)

Currency in KRW
1,300
-90(-6.47%)
Delayed Data·
Advertisement
216400 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,2001,350
52 wk Range
2225,800
Key Statistics
Bid/Ask
1,200.00 / 1,299.00
Prev. Close
1,390
Open
1,300
Day's Range
1,200-1,350
52 wk Range
222-5,800
Volume
104
Average Volume (3m)
650
1-Year Change
-56.3025%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
216400 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Biocore (216400) Income Statement & Profits

Compare 216400 to Peers and Sector

Metrics to compare
216400
Peers
Sector
Relationship
P/E Ratio
0.0x−0.2x−0.2x
PEG Ratio
0.000.040.00
Price/Book
0.0x1.0x2.6x
Price / LTM Sales
0.0x1.2x2.7x
Upside (Analyst Target)
-70.2%68.5%
Fair Value Upside
Unlock8.0%11.5%Unlock

Invites Biocore Co., Ltd. provides bioanalytical and central lab services in South Korea and internationally. It offers bioanalytical testing service during biological equivalence tests, clinical trials, toxicokinetics, nonclinical trials, vivo dynamic analysis, comparative dissolution test, and biomarker analysis; provides project strategic planning, medical translation, clinical research, quality assurance, monitoring, and data management for clinical services; and offers services, such as pharmaceutical quality control testing, emergency testing for food and drug safety, impurity testing, testing for licensed pharmaceutical products, and pharmaceutical stability testing. The company also provides disease susceptibility and anticancer drug susceptibility test; personalized genetic testing services, chromosomal microarray analysis, newborn screening, diagnostic exome sequencing, and non-invasive prenatal testing; and sequencing, microarray analysis, Real-Time PCR analysis services. In addition, it offers Real Time PCR Kits; ApoE genotype analysis products; and HLA-B*27 and HLA-B*51 genetic analysis products. Further, the company provides cold-chain and sample transport packaging, data logger device, as well as logistics services. The company was formerly known as Biocore Co., Ltd. and changed its name to Invites Biocore Co., Ltd. in March 2021. Invites Biocore Co., Ltd. was founded in 2001 and is headquartered in Seoul, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
2.89M37.54%4.02B
Public Companies & Retail Investors
4.82M62.46%6.69B
Total
7.71M100.00%10.72B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Invites Genomics CO., Ltd.29.06%2,240,9643,114,940
SBI Investment Korea Co., Ltd.7.40%570,574793,098

FAQ

What Is the Biocore (KONEX: 216400) Share Price Today?

The Biocore stock price today is 1,300 KRW.

What Stock Exchange Does Biocore (216400) Trade On?

Biocore is listed and trades on the Korea New Exchange.

What Is the Ticker (Stock Symbol) for Biocore?

The stock symbol (also called a 'ticker') for Biocore is "216400."

What Is the Current Biocore Market Capitalisation?

As of today, Biocore (KONEX: 216400) market cap is 10.72B KRW.

Is 216400 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Biocore moving averages and other technical indicators, the daily buy/sell signal for 216400 stock is Strong Sell.

How Many Times Has Biocore Stock Split?

Biocore has split 0 times. (See the 216400 stock split history page for full effective split date and price information.)

What is the current trading status of Biocore (KONEX: 216400)?

As of 18/11/2026, Biocore (216400) is trading at a share price of 1,300 KRW, with a previous close of 1,390 KRW. The stock has fluctuated within a day range of 1,200 KRW to 1,350 KRW, while its 52-week range spans from 222 KRW to 5,800 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.